FilingSEC EDGARS-8
Curanex Pharmaceuticals Files S-8 to Register Remaining Shares Under Equity Plan
· SEC accepted
StageRegistration Filed
Filing content
The company filed an S-8 registration statement to register the remaining 135,000 shares of common stock issuable under its 2026 Equity Incentive Plan.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…